)
)
Shenzhen YHLO Biotech Co Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Shenzhen YHLO Biotech Co
Access all reports
Shenzhen YHLO Biotech Co., Ltd., founded in 2008, is a Chinese company primarily focused on the research, development, manufacture, and sale of in-vitro diagnostic equipment and supporting reagents. The company's extensive product portfolio includes instruments and reagents based on chemiluminescence immunoassay, immunoblotting, enzyme-linked immunoassay, and immunofluorescence chromatography. These products are used in various medical fields, including autoimmunity, reproductive health, diabetes, and infectious diseases. The company is headquartered in Shenzhen, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
688575
Country
🇨🇳 China